Gene therapy for hemophilia is revolutionizing the way patients manage this challenging condition, ushering in a new era of hope and treatment possibilities.Recently, the groundbreaking Hemgenix gene therapy was approved for hemophilia B, targeting the underlying genetic mutations responsible for the disorder.